These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 10446965)
1. Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70s6K pathway in human pancreatic cancer cells. Grewe M; Gansauge F; Schmid RM; Adler G; Seufferlein T Cancer Res; 1999 Aug; 59(15):3581-7. PubMed ID: 10446965 [TBL] [Abstract][Full Text] [Related]
2. FRAP-p70s6K signaling is required for pancreatic cancer cell proliferation. Shah SA; Potter MW; Ricciardi R; Perugini RA; Callery MP J Surg Res; 2001 May; 97(2):123-30. PubMed ID: 11341787 [TBL] [Abstract][Full Text] [Related]
3. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Hidalgo M; Rowinsky EK Oncogene; 2000 Dec; 19(56):6680-6. PubMed ID: 11426655 [TBL] [Abstract][Full Text] [Related]
4. Posttranslational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells. Sueoka N; Lee HY; Walsh GL; Hong WK; Kurie JM Cancer Res; 1999 Aug; 59(15):3838-44. PubMed ID: 10447003 [TBL] [Abstract][Full Text] [Related]
5. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
6. Rapamycin inhibits constitutive p70s6k phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells. Seufferlein T; Rozengurt E Cancer Res; 1996 Sep; 56(17):3895-7. PubMed ID: 8752154 [TBL] [Abstract][Full Text] [Related]
7. Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro. Gorshtein A; Rubinfeld H; Kendler E; Theodoropoulou M; Cerovac V; Stalla GK; Cohen ZR; Hadani M; Shimon I Endocr Relat Cancer; 2009 Sep; 16(3):1017-27. PubMed ID: 19509067 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. Powell JD; Lerner CG; Schwartz RH J Immunol; 1999 Mar; 162(5):2775-84. PubMed ID: 10072524 [TBL] [Abstract][Full Text] [Related]
9. An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR. Hou G; Xue L; Lu Z; Fan T; Tian F; Xue Y Cancer Lett; 2007 Aug; 253(2):236-48. PubMed ID: 17360108 [TBL] [Abstract][Full Text] [Related]
10. Insulin restores differentiation of Ras-transformed C2C12 myoblasts by inducing NF-kappaB through an AKT/P70S6K/p38-MAPK pathway. Conejo R; de Alvaro C; Benito M; Cuadrado A; Lorenzo M Oncogene; 2002 May; 21(23):3739-53. PubMed ID: 12032842 [TBL] [Abstract][Full Text] [Related]
11. Phospholipase D confers rapamycin resistance in human breast cancer cells. Chen Y; Zheng Y; Foster DA Oncogene; 2003 Jun; 22(25):3937-42. PubMed ID: 12813467 [TBL] [Abstract][Full Text] [Related]
12. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases. Touyz RM; Yao G J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962 [TBL] [Abstract][Full Text] [Related]
13. Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells. Tong WG; Ding XZ; Talamonti MS; Bell RH; Adrian TE Anticancer Drugs; 2007 Jun; 18(5):535-41. PubMed ID: 17414622 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Kornmann M; Danenberg KD; Arber N; Beger HG; Danenberg PV; Korc M Cancer Res; 1999 Jul; 59(14):3505-11. PubMed ID: 10416617 [TBL] [Abstract][Full Text] [Related]
16. Growth inhibition in G(1) and altered expression of cyclin D1 and p27(kip-1 )after forced connexin expression in lung and liver carcinoma cells. Koffler L; Roshong S; Kyu Park I; Cesen-Cummings K; Thompson DC; Dwyer-Nield LD; Rice P; Mamay C; Malkinson AM; Ruch RJ J Cell Biochem; 2000 Sep; 79(3):347-54. PubMed ID: 10972973 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of wild type p70 S6 kinase interferes with cytokinesis. Sugiyama H; Papst P; Fujita M; Gelfand EW; Terada N Oncogene; 1997 Jul; 15(4):443-52. PubMed ID: 9242381 [TBL] [Abstract][Full Text] [Related]
18. Co-expression of cyclin D1 and phosphorylated ribosomal S6 proteins in hemimegalencephaly. Aronica E; Boer K; Baybis M; Yu J; Crino P Acta Neuropathol; 2007 Sep; 114(3):287-93. PubMed ID: 17483958 [TBL] [Abstract][Full Text] [Related]
19. The p70S6K signalling pathway: a novel signalling system involved in growth regulation. Grammer TC; Cheatham L; Chou MM; Blenis J Cancer Surv; 1996; 27():271-92. PubMed ID: 8909805 [TBL] [Abstract][Full Text] [Related]
20. Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Zhang H; Stallock JP; Ng JC; Reinhard C; Neufeld TP Genes Dev; 2000 Nov; 14(21):2712-24. PubMed ID: 11069888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]